Neurocrine Biosciences, the American biotech, has unveiled new data showing its drug Crenessity (crinecerfont) may help ...

Irish contract research organization ICON (Nasdaq: ICON) has retained its position as the most active CRO worldwide in the ...

Pathos AI, a US biotech specializing in artificial intelligence for cancer drug development, has raised $365 million in a ...

US clinical-stage biotech Therini Bio yesterday revealed that it raised $39 million in a Series A extension financing, which ...

New York-based Pathos AI, a biotech company applying artificial intelligence (AI) to drug development, has announced a $365 ...

The US Food and Drug Administration’s (FDA biosimilar approvals reached a record 19 in 2024, with projections indicating that ...

A federal jury in Delaware put US biotech major Amgen (Nasdaq: AMGN) on the hook Thursday for at least $271.2 million in ...

Chinese AI drug developer METiS Pharmaceuticals is preparing for a Hong Kong initial public offering that could raise up to $200 million, highlighting the ongoing surge of investment in artificial ...

A technology company specializing in the application of artificial intelligence to advance precision medicine and patient ...

US pharma giant Merck & Co (NYSE: MRK) today announced that the Phase III KEYNOTE-B96 trial, also known as ENGOT-ov65, met ...

New Jersey, USA-based cancer giant Merck & Co (NYSE: MRK) has announced it will unveil a comprehensive slate of new research ...

Swiss pharma giant Novartis will spotlight key data across its oncology portfolio, including Kisqali (ribociclib), Scemblix ...